Market Place
Sourcing Support
Teva hit with €463M fine over Copaxone misconduct claims in EU
30 Oct 2024 //
FIERCE PHARMA
Teva to pay $450M to settle longstanding kickback allegations
14 Oct 2024 //
FIERCE PHARMA
Synthon`s Generics Glatiramer Acetate Receives Approval in US
25 Sep 2024 //
FDA
Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US
25 Sep 2024 //
FDA
Teva Faces Fresh Copaxone Kickbacks Case From Medicare Providers
20 Aug 2024 //
FIERCE PHARMA
FDA Rejects Viatris, Mapi’s Long-Acting Multiple Sclerosis Injection
12 Mar 2024 //
BIOSPACE
Teva delays high-stakes kickbacks trial with rare early appeal
17 Aug 2023 //
FIERCE PHARMA
Obesity drugs don`t make WHO`s essential list, but Ebola, MS drugs added
27 Jul 2023 //
REUTERS
Stem cell transplants may slow disability progression in MS
22 Dec 2022 //
EUROPEANPHARMACEUTICALREVIEW
FDA alerts patients, and health care providers of cross-compatibility issues
18 Aug 2022 //
RAPS
Teva faces $100M claim by Israel over Copaxone royalties: report
11 May 2022 //
FIERCEPHARMA
COPAXONE Label Now Indicates Its Use in Breastfeeding Mothers with RMS
10 Feb 2022 //
BUSINESSWIRE
Multiple sclerosis drug improves memory in mice modeling Alzheimer’s disease
07 Nov 2021 //
FIRSTWORDPHARMA
Teva`s Austedo struggling from pandemic slowdown; All eyes on Q4
27 Oct 2021 //
FIERCEPHARMA
New Safety Data on treatment with COPAXONE of Breastfeeding Mothers with MS
13 Oct 2021 //
BUSINESSWIRE
Court denies Teva`s motion to dismiss Copaxone kickbacks case
12 Sep 2021 //
GLOBES
New Safety Data on treatment with COPAXONE of Breastfeeding Mothers
22 Jun 2021 //
BUSINESSWIRE
Uninhibited` price hikes, lobbying and more: Congressional probe gives detailed
30 Sep 2020 //
FIERCEPHARMA
Teva indicted on U.S. price-fixing charges after walking away from settlement
26 Aug 2020 //
FIERCEPHARMA
Hancock confirms replacement of Public Health England
19 Aug 2020 //
PHARMATIMES
US sues Teva over Copaxone co-pay assistance scheme
18 Aug 2020 //
RAPS
Mapi Pharma, Mylan Expand MS Alliance
15 Jun 2020 //
CONTRACTPHARMA
Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE®
22 May 2020 //
BUSINESSWIRE
Teva bails on price-fixing deal talks with the feds: report
19 May 2020 //
FIERCE PHARMA
Teva asks FDA to define Copaxone as biologics drug
27 Feb 2020 //
GLOBES
Teva Calls on FDA to Make Copaxone a Biologic as Part of March Transition
24 Feb 2020 //
RAPS
Teva’s weak pipeline hit by Tourette’s drug trial failure
21 Feb 2020 //
PMLIVE
Teva to pay $54m to settle Copaxone bribery case in US
07 Jan 2020 //
GLOBES
5 updates from Teva`s busy quarter:A new CFO, a biosimilar launch &migraine miss
09 Nov 2019 //
BIOPHARMA DIVE
Multiple sclerosis drug costs skyrocketed for Medicare and patients, study finds
27 Aug 2019 //
BIOPHARMADIVE
Sun Pharma chief, Dr. Reddy`s, Natco and more—FiercePharmaAsia
16 Aug 2019 //
FIERCE PHARMA
Dr. Reddy’s Copaxone, NuvaRing generics derailed by FDA
14 Aug 2019 //
FIERCE PHARMA
Mapi to establish $13m manufacturing plant for Copaxone generic
30 Jul 2019 //
IN-PHARMATECHNOLOGIST
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
21 Jun 2019 //
FIERCE PHARMA
Biogen trumpets safety data for Tecfidera follow-up
30 May 2019 //
PMLIVE
Novartis presents positive data from ASSESS study of Gilenya
11 May 2019 //
PHARMABIZ
Revenue plunges, stock takes a drubbing Teva CEO Kåre Schultz still grabs $32.5M
17 Apr 2019 //
ENDPTS
Medicare`s Uncapped Drug Costs Take A Big Bite From Already Tight Budgets
27 Mar 2019 //
NPR
Mylan shares sink as bleak profit outlook sparks growth concerns
28 Feb 2019 //
CNBC
Teva forecasts tough year as generics hammer Copaxone
13 Feb 2019 //
FIERCE PHARMA
JPM recap: Must-reads of the week, from FDA to IPO to M&A
12 Jan 2019 //
FIERCE PHARMA
Teva Threatened With Strike at Main Plant for Making Top-selling Copaxone Drug
07 Jan 2019 //
HAARETZ
Teva hit with $6.3M retaliation verdict in age, anti-American discrimination suit
04 Dec 2018 //
FIERCE PHARMA
Specialty Generics: Barriers To Uptake
13 Nov 2018 //
FORBES
Mylan`s generic Copaxone wins in court, but market barriers remain
17 Oct 2018 //
BIOPHARMA DIVE
Teva`s patent failure gives long-acting Copaxone generics free rein
15 Oct 2018 //
FIERCE PHARMA
U.S. appeals court upholds ruling that canceled Teva Copaxone patents
13 Oct 2018 //
REUTERS
Natco`s partner Mylan prevails over Teva in Copaxone patent litigation
13 Oct 2018 //
MONEY CONTROL
Novartis reports positive top-line data from Phase IIIb Gilenya trial
12 Oct 2018 //
DRUG DEVELOPMENT TECH
Novartis` Gilenya tops Teva giant Copaxone in head-to-head MS study
11 Oct 2018 //
FIERCE PHARMA
Novartis` Gilenya tops Teva giant Copaxone in head-to-head MS study
11 Oct 2018 //
FIERCE PHARMA
Novartis` Gilenya tops Teva giant Copaxone in head-to-head MS study
11 Oct 2018 //
FIERCE PHARMA
Teva Presents 25-year Safety Data on COPAXONE® (glatiramer acetate injection)
10 Oct 2018 //
BUSINESSWIRE
Was last week`s Teva sell-off warranted? Depends who you ask
03 Oct 2018 //
FIERCE PHARMA
Teva wins much-needed US approval of migraine drug
14 Sep 2018 //
BIOPHARMA DIVE
Teva finally dumps laquinimod, ending failure-riddled saga
05 Sep 2018 //
FIERCE BIOTECH
Pfizer responds to FDA, EMA and Canada after plant reinspections
21 Aug 2018 //
FIERCE PHARMA
A Deep Dive into Teva Pharma Financials Shows Significant Weakness and Optimism
09 Aug 2018 //
BIOSPACE
Teva raises earnings estimates despite continuing troubles
03 Aug 2018 //
PHARMA TIMES
Allergan sues Pfizer over costs of opioid litigation
03 Aug 2018 //
REUTERS
